TLSI logo

TLSITriSalus Life Sciences Inc

$3.64
$0.09
(2.54%)
Today
Closed $3.64
$0.11
(3.02%)
After Hours
Updated: 07:01 PM EDT
EarningsAug 11
Mkt Cap$218.03M
Vol353,052.00
News
all
press releases
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm PR Newswire LOS ANGELES, June 11, 2026 LOS ANGELES, June 11, 2026...
PR Newswire
News Placeholder
More News
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI PR Newswire NEW YORK, June 11, 2026 NEW YORK, June 11, 2026...
PR Newswire
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI PR Newswire NEW YORK, June 4, 2026 NEW YORK, June 4, 2026...
PR Newswire
News Placeholder
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TriSalus Life Sciences, Inc. (TriSalus or the Company) (NASDAQ: TLSI) for violations of the securities laws.The investigation focuses on whether the Company issued...
Business Wire
News Placeholder
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of TriSalus Life Sciences Inc. (TriSalus or the Company) (NASDAQ: TLSI) investors concerning the Companys possible violations of the federal securities...
Business Wire
News Placeholder
TriSalus Life Sciences Inc. (TLSI) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of TriSalus Life Sciences Inc. (TriSalus or the Company) (NASDAQ: TLSI) investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN TRISALUS LIFE SCIENCES INC...
Business Wire
News Placeholder
TLSI Investor Alert: Levi & Korsinsky Investigates TLSI (TLSI) for Potential Securities Fraud
Shareholders who held TriSalus Life Sciences Inc. (TLSI) stock lost money after the company cut its full-year 2026 revenue guidance to $54 million-$57 million, down from the $60 million-$62 million...
Business Wire
News Placeholder
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of TriSalus Life Sciences Inc. (TriSalus or the Company) (NASDAQ: TLSI) on behalf of investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TRISALUS LIFE SCIENCES INC...
Business Wire
News Placeholder
TriSalus Life Sciences Q1 2026 Earnings Call: Complete Transcript
read more...
Benzinga
News Placeholder
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of +12.50% and -15.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
<
1
2
...
>

Advertisement|Remove ads.